Tech Company Financing Transactions

AdvanCell Funding Round

AdvanCell, operating out of Sydney, NSW, secured $112 million in investment from Abingworth, Sanofi Ventures and SV Health Investors.

Transaction Overview

Company Name
AdvanCell
Announced On
2/3/2025
Transaction Type
Venture Equity
Amount
$112,000,000
Round
Series C
Investors

Abingworth (Lead Investor) (Bali Muralidhar)

Sanofi Ventures (Lead Investor) (Christopher Gagliardi)

SV Health Investors (Lead Investor) (Jamil Beg)

Symbiosis (Lead Investor)

Brandon Capital Partners

Morningside Ventures

Tenmile

Proceeds Purpose
The company intends to use the funds to advance ongoing efforts to expand its manufacturing capacity, accelerate the clinical development of its pipeline of radionuclide therapies, and advance its mission of delivering treatments to cancer patients worldwide.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Level 7, Macquarie House, 167 Macquarie St,
Sydney, NSW, 2000
AU
Phone
Undisclosed
Website
advancell.com.au/
Email Address
Undisclosed
Overview
AdvanCell is a radiopharmaceutical company developing next-generation cancer treatments. AdvanCell's targeted alpha therapies are powered by a platform technology -- a world-first alpha isotope generator which addresses the greatest unmet need in targeted alpha therapy -- the reliable and scalable supply of isotope.
Profile
AdvanCell LinkedIn Company Profile
Social Media
AdvanCell Company Twitter Account
Company News
AdvanCell News
Facebook
AdvanCell on Facebook
YouTube
AdvanCell on YouTube

Management Team

Title
Name
Email & Social
Chairman
Bill Ferris
  Bill Ferris LinkedIn Profile  Bill Ferris Twitter Account  Bill Ferris News  Bill Ferris on Facebook
Chief Executive Officer
Andrew Adamovich
  Andrew Adamovich LinkedIn Profile  Andrew Adamovich Twitter Account  Andrew Adamovich News  Andrew Adamovich on Facebook
Chief Technical Officer
Simon Puttick
  Simon Puttick LinkedIn Profile  Simon Puttick Twitter Account  Simon Puttick News  Simon Puttick on Facebook

 

 

Browse more venture capital transactions:

Prev: 2/3/2025: Nibertex venture capital transaction
Next: 2/3/2025: Diag-Nose.io venture capital transaction

 

Share this article

 

Where The Data Comes From

We record tech company VC transactions. VC transactions reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2025. Gaebler Ventures. All rights reserved.